These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15108425)

  • 1. Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
    Lee CO
    Clin J Oncol Nurs; 2004 Apr; 8(2):212-4. PubMed ID: 15108425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Cancer Institute's OCCAM partners with NCCAM to expand research on unconventional cancer treatments.
    Muscat M
    Altern Ther Health Med; 1999 Jul; 5(4):26-30. PubMed ID: 10394671
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine research: a National Cancer Institute perspective.
    White JD
    Semin Oncol; 2002 Dec; 29(6):546-51. PubMed ID: 12516037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Research and the OCCAM.
    Smith W
    Explore (NY); 2007; 3(4):396-403. PubMed ID: 17681261
    [No Abstract]   [Full Text] [Related]  

  • 7. The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India.
    Olaku O; Zia F; Santana JM; White JD
    Integr Cancer Ther; 2013 Sep; 12(5):385-92. PubMed ID: 23355475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA.
    Banerji P; Campbell DR; Banerji P
    Oncol Rep; 2008 Jul; 20(1):69-74. PubMed ID: 18575720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the best case series methodology: best case series results of East-West Cancer Center.
    Yoo HS; Cho CK; Hong MS
    Integr Cancer Ther; 2008 Sep; 7(3):182-8. PubMed ID: 18815149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Outcomes of Cancer Outcomes Research: focusing on the National Cancer Institute's quality-of-care initiative.
    Lipscomb J; Snyder CF
    Med Care; 2002 Jun; 40(6 Suppl):III3-10. PubMed ID: 12064755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best case series 'SWAT' teams: AHRQ/NCCAM/RAND partnership facilitates review of CAM cancer treatments.
    Muscat M
    Altern Ther Health Med; 2001; 7(5):24-6. PubMed ID: 11565398
    [No Abstract]   [Full Text] [Related]  

  • 13. National Cancer Institute's Native American cancer research projects.
    Burhansstipanov L
    Alaska Med; 1993; 35(4):248-54. PubMed ID: 8160917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAM evaluation comes into the mainstream: NIH specialized Centers of research and the University of Maryland Center for Alternative Medicine Research in Arthritis.
    Berman BM; Hartnoll S; Bausell B
    Complement Ther Med; 2000 Jun; 8(2):119-22. PubMed ID: 10859605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide.
    Minig L; Trimble EL; Birrer MJ; Kim KY; Takebe N; Abrams JS
    Gynecol Oncol; 2010 Feb; 116(2):177-80. PubMed ID: 19889449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Cancer Institute's Small Grants Program for behavioral research in cancer control boosts careers for new investigators and fulfills NIH research priorities.
    Chollette VY; Crowley K
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2459-63. PubMed ID: 18006937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
    White JD
    J Altern Complement Med; 2002 Oct; 8(5):545-50. PubMed ID: 12470434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative cancer medicine.
    Cassileth BR
    J Clin Oncol; 1999 Nov; 17(11 Suppl):44-52. PubMed ID: 10630262
    [No Abstract]   [Full Text] [Related]  

  • 20. Technical information programs of the National Cancer Institute.
    Masys DR; Hubbard SM
    J Am Soc Inf Sci; 1987 Jan; 38(1):60-4. PubMed ID: 10301371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.